Pillstats
Rx only · Tablet, Film Coated · Oral

Doxepin

Doxepin Hydrochloride

4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
4 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD04AX01
RxCUI (US)3638
US makers4 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.558$1.12$1.67$2.23Dec 2025Apr 2026Jul 2026
$1.406
Latest avg · Jul 22, 2026
-28%
Since Dec 17, 2025
4
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.1K2.2K3.3K4.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2K
Rx · 2026 Q1
35K
Units dispensed
-68%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it4 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Archis Pharma LLCunknown6SUPPLYING
Actavis Pharma, Inc.unknown2SUPPLYING
NorthStar Rx LLCunknown2SUPPLYING
Marlex Pharmaceuticals Incunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.